Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Starr_Hazard
    Member
    • Nov 2010
    • 19

    #1

    CuffDiff and Significant Splicing events

    Folks,

    We are looking at RNASeq data from rat brain.
    The experimental protocol is to compare sham (or S: saline treated) versus experimental (or C: chemical treated).
    Several pairs of animals were tested.


    When I group all the data from groups 1, 2 & 3 the number of genes with significantly different expression ( ie with "yes" in *.diff from cuffdiff output) can be a few score of genes. However, when I look a the C vs S for a single pair I can see several thousand genes, isoforms splicing variants. Why the huge decrease? I tell the experimentalists that this may be due to the multiple test corrections but they are not convinced.


    When I examine pairs separately ( ie group 1 C vs S, group 2 C vs S and group 3 C vs S) I get a number of significant genes and isoforms that show common expression patterns in all groups.
    However the number of splicing events shows almost no instances where the same event is found in all three groups. Why is that?


    Starr
  • endether
    Member
    • Feb 2011
    • 11

    #2
    Hi Starr,

    Firstly, I don't think it is a result of multiple test correction, because it is only related to your number of tests, which should be the total number of candidate genes/splicing events.

    I assume you have multiple groups within each 'test groups' (S and C respectively). It might be the case that the variance among your groups is so big that the S vs C variance is less significant. For example, if there are 3 groups (or individuals?) in S and C, one feature (gene/splicing event ) has following values S1 = 1, S2 = 10, S3 = 5 and C1 = 10, C2=1, C3=2. If you look at S1 vs C1, S2 vs C2, and S2 vs C3, you might draw the false conclusion that it is deferentially expressed when comparing S and C. However, if you take them together and compare (S1, S2, S3) vs (C1, C2, C3), you cannot safely say that they are different because it is totally possible that the difference between S1 and C1 is a result of system variance (noise or individual difference) instead of biological variance (your treatment).

    Of course, if you have multiple individuals in each group and you believe there are difference between groups, you might want to stick with the group-wise test.

    Best,
    Zheng

    Comment

    • glados
      Member
      • Mar 2012
      • 59

      #3
      I had this problem as well. When I increased the sample size, the number if sig. genes decreased drastically in cuffdiff. However I got the opposite result in DESeq, much more sig. genes with more replicates.

      Comment

      • DZhang
        Senior Member
        • Jun 2010
        • 177

        #4
        Hi Starr,

        What you observed supports the notion that technical or biological replicates should be utilized to reduce the false positives in differential expression analysis. However, you need to keep in mind that maybe there are some real differences among these three pairs so when individually compared they have many hits but grouped together they are either canceled out or get buried. What I recommend is to ask the bench scientists 1) are the pairs matched, age-wise, sex-wise, etc.? 2) were there any difference among these three pairs in terms of how the experiments were conducted; 3) you may have to ask them to perform validation experiments (say, qPCR) on a limited scale.

        Best regards,
        Douglas

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        25 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        31 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-13-2026, 09:56 AM
        0 responses
        27 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-09-2026, 11:14 AM
        0 responses
        28 views
        0 reactions
        Last Post SEQadmin2  
        Working...